Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 26 04:00PM ET
17.11
Dollar change
+0.44
Percentage change
2.64
%
IndexRUT P/E- EPS (ttm)-3.18 Insider Own5.04% Shs Outstand139.51M Perf Week23.54%
Market Cap2.40B Forward P/E- EPS next Y-0.09 Insider Trans-1.07% Shs Float133.33M Perf Month30.51%
Income-398.71M PEG- EPS next Q0.98 Inst Own48.81% Short Float23.55% Perf Quarter333.16%
Sales996.61M P/S2.41 EPS this Y107.83% Inst Trans3.20% Short Ratio1.84 Perf Half Y317.32%
Book/sh-6.18 P/B- EPS next Y-121.73% ROA-27.53% Short Interest31.40M Perf Year108.15%
Cash/sh3.50 P/C4.89 EPS next 5Y37.90% ROE- 52W Range3.53 - 23.86 Perf YTD256.46%
Dividend Est.- P/FCF- EPS past 5Y11.55% ROI- 52W High-28.29% Beta1.94
Dividend TTM- Quick Ratio0.88 Sales past 5Y513.29% Gross Margin64.69% 52W Low384.37% ATR (14)1.36
Dividend Ex-DateDec 13, 2007 Current Ratio0.90 EPS Y/Y TTM78.36% Oper. Margin-37.92% RSI (14)62.33 Volatility9.49% 8.36%
Employees1543 Debt/Eq- Sales Y/Y TTM-26.66% Profit Margin-40.01% Recom2.00 Target Price21.40
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q69.08% Payout- Rel Volume0.42 Prev Close16.67
Sales Surprise-7.22% EPS Surprise1.32% Sales Q/Q15.94% EarningsMay 10 BMO Avg Volume17.05M Price17.11
SMA2023.46% SMA5015.98% SMA200125.55% Trades Volume7,125,461 Change2.64%
Date Action Analyst Rating Change Price Target Change
May-10-24Upgrade JP Morgan Underweight → Neutral
May-10-24Upgrade BofA Securities Underperform → Neutral $4 → $12
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Sep-22-22Downgrade JP Morgan Neutral → Underweight $132 → $27
May-20-22Initiated BofA Securities Underperform $35
Jul-25-24 01:28PM
Jul-23-24 09:41AM
Jul-16-24 09:00AM
Jul-15-24 09:30AM
Jul-08-24 05:45PM
06:55AM Loading…
Jul-03-24 06:55AM
Jul-02-24 08:30AM
Jul-01-24 11:00PM
07:38AM
Jun-29-24 08:55AM
08:35AM
Jun-28-24 05:45PM
06:30AM
Jun-27-24 02:21PM
Jun-25-24 07:00PM
04:37PM Loading…
04:37PM
11:42AM
06:33AM
Jun-24-24 09:18AM
09:00AM
Jun-22-24 03:42AM
Jun-20-24 05:45PM
Jun-18-24 10:29AM
05:52AM
Jun-17-24 12:02PM
04:32AM
Jun-14-24 02:05PM
04:55AM
Jun-13-24 11:02AM
Jun-11-24 06:00AM
05:10AM Loading…
05:10AM
Jun-10-24 09:00AM
Jun-07-24 07:30AM
Jun-06-24 04:37PM
04:15PM
11:38AM
10:48AM
09:58AM
09:28AM
Jun-05-24 04:51PM
Jun-04-24 06:00AM
Jun-03-24 05:43PM
03:41PM
01:23PM
Jun-01-24 06:01AM
May-31-24 06:57AM
May-30-24 09:25AM
May-28-24 09:00AM
May-24-24 05:55PM
08:15AM
May-23-24 12:45PM
06:45AM
May-22-24 10:48AM
09:45AM
05:50AM
May-21-24 09:01AM
06:27AM
May-20-24 03:29PM
02:31PM
01:53PM
01:37PM
07:40AM
07:39AM
06:35AM
May-19-24 08:49AM
May-18-24 07:35AM
May-17-24 06:45AM
05:40AM
May-16-24 09:15AM
06:34AM
May-15-24 02:31PM
08:00AM
06:48AM
06:32AM
05:35AM
May-14-24 11:01AM
10:24AM
06:47AM
05:11AM
May-13-24 04:02PM
12:51PM
10:24AM
03:03AM
May-10-24 06:56PM
05:56PM
04:26PM
04:16PM
04:11PM
04:08PM
02:54PM
01:58PM
01:46PM
01:44PM
01:27PM
01:24PM
01:24PM
01:08PM
01:07PM
01:02PM
12:49PM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YOUNG JAMES FDirectorJun 21 '24Sale14.097,500105,67561,760Jun 25 04:12 PM
YOUNG JAMES FDirectorJun 18 '24Sale13.727,500102,88169,260Jun 21 04:21 PM
Dubovsky FilipPresident, R&DJun 17 '24Option Exercise6.1813,90485,91180,517Jun 20 05:08 PM
Dubovsky FilipPresident, R&DJun 17 '24Sale14.4713,904201,16466,613Jun 20 05:08 PM
MCGLYNN MARGARET GDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:14 PM
Alton Gregg HDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:11 PM
DOUGLAS RICHARDDirectorJun 12 '24Option Exercise0.006,670043,920Jun 14 04:10 PM
MOTT DAVID MDirectorJun 12 '24Option Exercise0.006,670050,470Jun 14 04:06 PM
King Rachel K.DirectorJun 12 '24Option Exercise0.006,670018,920Jun 14 04:07 PM
Rodgers Richard JDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:05 PM
YOUNG JAMES FDirectorJun 12 '24Option Exercise0.006,670076,760Jun 14 04:01 PM
Dubovsky FilipPresident, R&DMay 14 '24Option Exercise6.9719,652136,97486,265May 15 09:15 PM
Dubovsky FilipPresident, R&DMay 14 '24Sale13.9047,312657,63738,953May 15 09:15 PM
O'Hara ElaineEVP, Chief Strategy OfficerMar 01 '24Option Exercise5.3919,600105,64419,600Mar 05 07:30 PM
Dubovsky FilipPresident, R&DDec 14 '23Option Exercise5.692,83316,12055,150Dec 18 05:00 PM
Dubovsky FilipPresident, R&DNov 05 '23Option Exercise7.061,4009,88452,994Nov 07 05:30 PM
Dubovsky FilipPresident, R&DSep 16 '23Option Exercise7.7112,64497,48557,702Sep 19 05:16 PM